BioMarin Pharmaceutical Inc. buy StockNews.com
Start price
29.04.23
/
50%
€88.08
Target price
29.04.24
-
Performance (%)
-13.03%
End price
30.04.24
€76.60
Summary
This prediction ended on 30.04.24 with a price of €76.60. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.03%. StockNews_com has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.079% | -0.079% | -23.691% |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% |
Comments by StockNews_com for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€65.26
22.02.25
22.02.25
-
22.02.26
22.02.26
-22.31%
09.01.26
09.01.26
Stopped prediction by StockNews_com for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€66.60
10.03.25
10.03.25
-
10.03.26
10.03.26
-23.87%
09.01.26
09.01.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€67.70
02.03.25
02.03.25
-
02.03.26
02.03.26
-25.11%
09.01.26
09.01.26